Skip to main content
Premium Trial:

Request an Annual Quote

Merck and BGI Collaborating on Biomarker Discovery, Development of Genomic Technologies

Premium

Merck and China's BGI said this week that they are collaborating to discover and characterize diagnostic and drug development biomarkers "across a wide range of therapeutic areas" and to develop genomic technologies.

Both partners will propose projects and provide resources, expertise, samples, and other research material to conduct them.

The strategic collaboration combines BGI's capabilities in genome sequencing and analysis and Merck's expertise in drug development. The partners "hope to apply BGI's comprehensive next-gen sequencing solutions to develop important new tools to aid drug development and enable effective tailoring of medicines to those patients most likely to respond," according to Jeffrey Chodakewitz, vice president of late stage development at Merck Research Laboratories.

The new agreement follows a "statement of intent" to collaborate that the two partners signed a year ago (IS 9/21/2010), with the "goal of creating value from the massive output of genomic information enabled by next-generation, high-throughput DNA sequencing and analysis technologies."

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.